XML 61 R44.htm IDEA: XBRL DOCUMENT v3.25.0.1
CAPITAL STOCK (Tables)
12 Months Ended
Dec. 28, 2024
Equity [Abstract]  
Schedule of Net Earnings (Loss) Attributable to Common Shareowners and Weighted-Average Shares outstanding The following table reconciles net earnings (loss) attributable to common shareowners and the weighted-average shares outstanding used to calculate basic and diluted earnings (loss) per share for the fiscal years ended December 28, 2024, December 30, 2023, and December 31, 2022.
202420232022
Numerator (in millions):
Net Earnings (Loss) from Continuing Operations Attributable to Common Shareowners$286.3 $(281.7)$164.3 
Add: Contract adjustment payments accretion — 1.2 
Net Earnings (Loss) from Continuing Operations Attributable to Common Shareowners - Diluted286.3 (281.7)165.5 
Net earnings (loss) from discontinued operations8.0 (28.8)892.4 
Net Earnings (Loss) Attributable to Common Shareowners - Diluted$294.3 $(310.5)$1,057.9 
202420232022
Denominator (in thousands):
Basic weighted-average shares outstanding150,485 149,751 148,170 
Dilutive effect of stock contracts and awards812 — 8,383 
Diluted weighted-average shares outstanding151,297 149,751 156,553 

Earnings (loss) per share of common stock:
Basic earnings (loss) per share of common stock:
Continuing operations$1.90 $(1.88)$1.11 
Discontinued operations$0.05 $(0.19)$6.02 
Total basic earnings (loss) per share of common stock$1.96 $(2.07)$7.13 
Diluted earnings (loss) per share of common stock:
Continuing operations$1.89 $(1.88)$1.06 
Discontinued operations$0.05 $(0.19)$5.70 
Total diluted earnings (loss) per share of common stock$1.95 $(2.07)$6.76 
Schedule of Weighted-Average Stock Options Not Included in Computation of Weighted-Average Diluted Shares Outstanding
The following weighted-average stock options were not included in the computation of weighted-average diluted shares outstanding because the effect would be anti-dilutive (in thousands):
202420232022
Number of stock options5,141 5,406 4,019 
Schedule of Common Stock Share Activity Common stock activity for 2024, 2023 and 2022 was as follows:
202420232022
Outstanding, beginning of year153,620,088 152,983,530 163,328,776 
Issued from treasury960,437 817,110 5,711,974 
Returned to treasury(207,592)(180,552)(16,057,220)
Outstanding, end of year154,372,933 153,620,088 152,983,530 
Shares subject to the forward share purchase contract(3,645,510)(3,645,510)(3,645,510)
Outstanding, less shares subject to the forward share purchase contract150,727,423 149,974,578 149,338,020 
Schedule of Common Stock Shares Reserved for Issuance Under Various Employee and Director Stock Plans Common stock shares reserved for issuance under various employee and director stock plans at December 28, 2024 and December 30, 2023 are as follows:
 
20242023
Employee stock purchase plan921,982 1,070,126 
Other stock-based compensation plans5,869,501 6,161,350 
Total shares reserved6,791,483 7,231,476 
Schedule of Weighted Average Assumptions Used to Value Grants The following weighted-average assumptions were used to value grants made in 2024, 2023 and 2022:
202420232022
Average expected volatility38.0 %39.1 %38.6 %
Dividend yield3.6 %3.6 %3.7 %
Risk-free interest rate4.2 %4.0 %3.2 %
Expected life5.0 years5.0 years4.2 years
Fair value per option$25.25 $26.05 $20.00 
Weighted-average vesting period2.0 years1.9 years1.7 years
Schedule of Number of Stock Options and Weighted-average Exercise Prices
The number of stock options and weighted-average exercise prices as of December 28, 2024 are as follows:
 OptionsPrice
Outstanding, December 30, 20235,490,848 $133.22 
Granted832,331 89.34 
Exercised(163,179)89.19 
Forfeited(241,429)125.24 
Outstanding, December 28, 20245,918,571 $128.59 
Exercisable, December 28, 20244,339,550 $140.93 
Schedule of Outstanding and Exercisable Stock Option
Outstanding and exercisable stock option information at December 28, 2024 follows:
 Outstanding Stock OptionsExercisable Stock Options
Exercise Price RangesOptionsWeighted-
Average
Remaining
Contractual Life
Weighted-
Average
Exercise Price
OptionsWeighted-
Average
Remaining
Contractual Life
Weighted-
Average
Exercise Price
$100.00 and below
2,183,691 8.46$86.00 719,340 8.04$82.46 
100.01 — 165.00
2,055,411 3.38131.22 2,040,881 3.35131.38 
165.01 — higher
1,679,469 5.30180.74 1,579,329 5.19179.90 
5,918,571 5.80$128.59 4,339,550 4.80$140.93 
Schedule of Non-Vested Restricted Share Units and Activity Pertaining to Maximum Number of Shares that may be Issued
A summary of non-vested restricted share units and award activity as of December 28, 2024, and changes during the year then ended is as follows:
Restricted Share
Units & Awards
Weighted-Average
Grant
Date Fair Value
Non-vested at December 30, 20231,490,924 $100.24 
Granted750,126 89.66 
Vested(585,745)99.85 
Forfeited(175,322)96.78 
Non-vested at December 28, 20241,479,983 $95.44 
A summary of the activity pertaining to the maximum number of shares that may be issued is as follows:
LTIP UnitsWeighted-Average
Grant
Date Fair Value
Non-vested at December 30, 2023731,128 $119.90 
Granted468,228 80.86 
Vested(15,562)163.45 
Forfeited(164,646)149.63 
Non-vested at December 28, 20241,019,148 $96.50